Epigral Limited — Others, 05-05-2025: Monitoring Agency Report

Epigral Limited has announced a monitoring agency report from CARE Ratings confirming full and timely utilization of Rs. 333.05 Cr raised via QIP. The funds were allocated as planned: Rs. 250 Cr for debt repayment, Rs. 30 Cr for capex, Rs. 44.72 Cr for general corporate purposes, and Rs. 8.33 Cr for issue expenses. No deviations or delays impacted project timelines or business operations, highlighting disciplined capital management that supports Epigral’s growth and debt reduction strategy.